Givinostat reduces adverse cardiac remodeling through regulating fibroblasts activation

Cardiovascular diseases (CVDs) are a major burden on the healthcare system: indeed, over two million new cases are diagnosed every year worldwide. Unfortunately, important drawbacks for the treatment of these patients derive from our current inability to stop the structural alterations that lead to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Cell Death Dis
Main Authors: Milan, Marika, Pace, Valentina, Maiullari, Fabio, Chirivì, Maila, Baci, Denisa, Maiullari, Silvia, Madaro, Luca, Maccari, Sonia, Stati, Tonino, Marano, Giuseppe, Frati, Giacomo, Puri, Pier Lorenzo, De Falco, Elena, Bearzi, Claudia, Rizzi, Roberto
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5833837/
https://ncbi.nlm.nih.gov/pubmed/29371598
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41419-017-0174-5
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki